DEL PAPA, BEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 1.472
EU - Europa 1.264
AS - Asia 511
SA - Sud America 33
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.289
Nazione #
US - Stati Uniti d'America 1.463
IT - Italia 364
IE - Irlanda 292
SG - Singapore 177
HK - Hong Kong 121
DE - Germania 110
CN - Cina 109
SE - Svezia 98
UA - Ucraina 98
FI - Finlandia 70
RU - Federazione Russa 64
VN - Vietnam 51
RO - Romania 40
GB - Regno Unito 38
BR - Brasile 25
BE - Belgio 22
KR - Corea 22
FR - Francia 17
CZ - Repubblica Ceca 16
TR - Turchia 12
AT - Austria 10
CA - Canada 7
CH - Svizzera 6
UZ - Uzbekistan 6
CI - Costa d'Avorio 5
IN - India 5
EC - Ecuador 4
LT - Lituania 4
GR - Grecia 3
NL - Olanda 3
PL - Polonia 3
LB - Libano 2
MX - Messico 2
PE - Perù 2
PT - Portogallo 2
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
GH - Ghana 1
ID - Indonesia 1
IM - Isola di Man 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
PY - Paraguay 1
SC - Seychelles 1
Totale 3.289
Città #
Chandler 294
Dublin 292
San Mateo 193
Perugia 186
Hong Kong 121
Singapore 121
Boardman 80
Ann Arbor 70
Santa Clara 55
Jacksonville 54
Dong Ket 51
Altamura 48
Medford 46
Princeton 45
Beijing 41
Bucharest 40
Andover 38
Helsinki 38
Wilmington 36
Lawrence 35
Foligno 33
New York 25
Brussels 22
Seoul 22
Dearborn 21
Redwood City 19
Los Angeles 16
Ashburn 13
Brno 12
Des Moines 12
Munich 12
Norwalk 12
Assisi 11
Izmir 11
Moscow 11
Woodbridge 10
Dallas 9
Falls Church 8
Houston 8
Saint Petersburg 8
San Paolo di Civitate 8
Falkenstein 6
Shanghai 6
Vienna 6
Abidjan 5
Bastia 4
Ottawa 4
Redmond 4
Rome 4
Aurora 3
Collazzone 3
Guangzhou 3
Quito 3
São Paulo 3
Auburn Hills 2
Bengaluru 2
Bhubaneswar 2
Bologna 2
Changsha 2
Chicago 2
Council Bluffs 2
Frankfurt Am Main 2
Lappeenranta 2
London 2
Macerata 2
Melissa 2
Nuremberg 2
Olomouc 2
Selargius 2
São José dos Campos 2
Toronto 2
West Jordan 2
Amsterdam 1
Apo 1
Aragarças 1
Bagé 1
Baku 1
Battipaglia 1
Bekasi 1
Bragança 1
Campo Grande 1
Campo Largo 1
Campobasso 1
Catania 1
Chittagong 1
Civitanova Marche 1
Copenhagen 1
Delhi 1
Den Haag 1
Douglas 1
Formosa 1
Franca 1
Frankfurt am Main 1
Fremont 1
Groningen 1
Guadalupe 1
Hanover 1
Hefei 1
Itaquaquecetuba 1
Jinan 1
Totale 2.305
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 134
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 120
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 118
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 111
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 100
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 95
Mesenchymal cells: a vehicle for gene therapy 94
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 86
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 83
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 82
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 79
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 77
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 76
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 75
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 75
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 75
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 74
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 74
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 72
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 70
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 70
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 69
T regulatory cell separation for clinical application. 69
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 64
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 62
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 62
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 61
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 60
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 59
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 59
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 59
Exploring the radiosensitizing potential of AZD8931: a pilot study on the human LoVo colorectal cancer cell line 56
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 55
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 55
New mechanism of lymphoma-induced bone marrow aplasia 54
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 53
Interleukin 7-engineered stromal cells: a new approach for hastening naive T cell recruitment 52
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 52
Mesenchymal cells recruit and regulate T regulatory cells. 49
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 48
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 48
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 47
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 45
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 44
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 42
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 38
null 37
NOTCH and Graft-Versus-Host Disease 36
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 35
Catalase prevents DNA damage and cationic current activation by silver nanoparticles in U251 human glioblastoma cell line 33
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 32
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 32
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 30
Totale 3.437
Categoria #
all - tutte 15.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020121 0 0 0 0 0 0 0 0 27 70 8 16
2020/2021370 9 15 21 16 104 32 27 4 38 14 31 59
2021/2022605 12 174 8 21 14 6 9 124 4 55 81 97
2022/2023910 48 169 8 82 75 83 0 45 346 1 35 18
2023/2024441 19 44 27 23 2 17 137 6 16 20 57 73
2024/2025470 41 82 19 43 93 29 44 55 64 0 0 0
Totale 3.437